Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder
Phenomenology Observational high
AI-extracted · unverified · confirm at source
43% of 42 ibogaine-treated OUD participants achieved complete mystical experience on SCQ; qualitative themes of confrontation, remorse, letting go, and transformation emerged
Dosing: 22.5 ± 10.1 mg/kg HCl (Mexico, n=26); 31.4 ± 7.6 mg/kg HCl (NZ, n=14); 9.9 ± 7.8 mg/kg HCl + 18.7 ± 17.3 mg/kg crude rootbark extract (Mexico, n=4) (oral)
Sample size: 44
Contraindications: Substance use disorders other than opioid dependence, Previous ibogaine treatment, Physical or psychosocial problems preventing compliance with study requirements